Pacira Pharma (PCRX): Survey Suggests Clouds May Be Lifting - Jefferies
Tweet Send to a Friend
Jefferies analyst, David Steinberg, reiterated his Buy rating on shares of Pacira Pharmaceuticals (NASDAQ: PCRX) after a Physician/Payer surveys suggest ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE